Titre:
  • A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma.
Auteur:Nicolle, R; Gayet, O; Duconseil, P; Vanbrugghe, C; Roques, Julie; Bigonnet, M; Blum, Yuna; Elarouci, Nabila; Armenoult, L; Ayadi, M; de Reyniès, Aurélien; Puleo, Francesco; Augustin, J; Emile, J F; Svrcek, Magali; Arsenijevic, Tatjana; Hammel, P; Giovannini, M; Grandval, P; Dahan, Laeticia; Moutardier, V; Gilabert, M; Van Laethem, Jean-Luc; Bachet, J B; Cros, Jérôme; Iovanna, J; Dusetti, N J
Informations sur la publication:Annals of oncology
Statut de publication:Publié, 2020-11-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Chemosensitivity Prediction
Gemcitabine
Pancreatic Cancer
Precision medicine
Transcriptomic Signature
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1016/j.annonc.2020.10.601
info:pii/S0923-7534(20)43131-X
info:pmid/33188873